Indian researchers have developed a new Visceral Leishmaniasis therapy

Indian researchers have developed a non-invasive, easy to administer, cost-effective, and patient compliant potential therapeutic strategy against Visceral Leishmaniasis.

Daily Current Affairs Quiz 2021

Their strategy based on nano carrier-based oral drugs coated with Vitamin B12 enhanced oral bioavailability and efficacy of the therapy by more than 90%.

Visceral Leishmaniasis (VL) is a complex infectious disease transmitted by the bite of female Phlebotomine sandflies.

It is a neglected tropical disease that affects millions annually, making it the second most common parasitic killer after malaria.